With this 50% increase in its global capacities announced in July 2017, the Group supports strong demand from its customers in Asia for high-performance bio-sourced solutions addressing the major opportunity of material lightweighting in particular.
Arkema has chosen the Jurong Island site in Singapore to set up its new bio-sourced polyamide production site. This location offers many advantages in terms of infrastructure, logistics, industrial integration and operational excellence, as well as optimization of the activity’s carbon footprint.
“This major investment bolsters our global presence in bio-sourced materials while bringing us significantly closer to our customers in Asia” stated Erwoan Pezron, Global Group President for Arkema’s Technical Polymers business line. “Singapore’s industrial and innovation-friendly environment is, we believe, a key asset for our project.”
Rilsan® polyamide 11 is derived from castor oil and so is the only 100% bio-sourced polyamide approved for many of the most demanding applications, in particular in the electronics, 3D printing, oil and gas extraction, and automotive markets, as a substitute to metal.
This project is part of the Group’s exceptional investments totaling some 500 million euros earmarked for the 2018-2021 period essentially. Construction is scheduled to be completed by late 2021.
- What are Bioplastics and Biopolymers?
- Bioplastics Brands
- Bioplastics Awards
- What is the Difference Between Biodegradable, Compostable and OXO Degradable?
- The History and Most Important Innovations of Bioplastics
- What are Drop-In Bioplastics?
- History of Cellophane
- The History of Elephant Grass Bioplastics
- Bioplastics Companies
- Top Bioplastics Producers
- Polylactic acid or polylactide (PLA)
- What is Bio-BDO?
- McDonalds and the Polystyrene Connections
- The Future of Polystyrene
- Bioplastic Feedstock 1st, 2nd and 3rd Generations
- Palm Oil and The Bioplastics Industry